The core facility flow cytometry CFFC at the German Cancer Research Center DKFZ is jointly operated with HI-STEM and has immediate opening for a FACS operator.
This core facility is currently expanded to twelve instruments, four sorters and eight analyzers, and provides different flow cytometry services to over 250 investigators within the DKFZ and HI-STEM.
We are seeking a highly motivated FACS operator
Although the primary duties are the maintenance and daily operation of one of our cell sorters (BD- FACSAria SORP), you will also be involved in the other operations of a busy research core facility, including quality control, setting up multicolor experiments as well as teaching, training and supervising of users. Candidates must be self-motivated, able to work independently and as part of a team currently, consisting of three operators. Excellent interpersonal skills are essential to establish good relationships with researchers and attention to detail to ensure accurate work and record keeping, as well as a flexible schedule are also very desirable. The communication language is predominately English.
Required educational background and experience
Successful applicants should be qualified as a medical-, biological-, chemical technical assistance (MTA / BTA / CTA) or a have a Bachelor‘s degree from an accredited college, university or in a field related to biomedical research.
A minimum of one year of relevant work experience is required. Knowledge of different flow cytometric analysis software (e.g. FlowJo, DIVA, CellQuest, Summit, etc.) as well as hands-on experience with flow cytometers and especially cell sorters is desirable. Good communication skills in English are essential.
The position is initially restricted for two years with the option for extension.
The Stem Cell Institute
HI-STEM gGmbH is a non-profit public-private partnership between the German Cancer Research Center (DKFZ) in Heidelberg and the Dietmar Hopp Foundation.
HI-STEM performs cutting-edge research on stem cells with the aim of translating these results into novel clinical applications. This includes the development of novel diagnostic tools and innovative therapies to monitor and target leukemic and solid tumor stem cells as well as metastatic disease.
Please send your application with CV and reference letters by email to: